Royal Bank of Canada
APYX icon

Royal Bank of Canada’s Apyx Medical APYX Stock Holding History

Royal Bank of Canada’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Buy
4,821
+827
+21% +$3.09K ﹤0.01% 5933
2025
Q4 		$14K Sell
3,994
-3,300
-45% -$11.5K ﹤0.01% 6225
2025
Q3 		$16K Buy
7,294
+2,800
+62% +$5.93K ﹤0.01% 6296
2025
Q2 		$10K Buy
4,494
+500
+13% +$704 ﹤0.01% 6469
2025
Q1 		$5K Hold
3,994
– – ﹤0.01% 6338
2024
Q4 		$6K Hold
3,994
– – ﹤0.01% 6473
2024
Q3 		$5K Sell
3,994
-285
-7% -$360 ﹤0.01% 6482
2024
Q2 		$5K Buy
4,279
+265
+7% +$391 ﹤0.01% 6521
2024
Q1 		$5K Sell
4,014
-20,084
-83% -$42.7K ﹤0.01% 6420
2023
Q4 		$63K Buy
24,098
+4,144
+21% +$10K ﹤0.01% 5879
2023
Q3 		$64K Buy
+19,954
New +$93K ﹤0.01% 5637
2022
Q2 		– Sell
-1,915
Closed -$13K – 7341
2022
Q1 		$13K Sell
1,915
-7,103
-79% -$70K ﹤0.01% 6824
2021
Q4 		$116K Buy
9,018
+3,559
+65% +$49.8K ﹤0.01% 5824
2021
Q3 		$76K Buy
5,459
+3,323
+156% +$35K ﹤0.01% 5894
2021
Q2 		$22K Sell
2,136
-359
-14% -$3.56K ﹤0.01% 6512
2021
Q1 		$24K Buy
2,495
+1,291
+107% +$12.9K ﹤0.01% 6322
2020
Q4 		$9K Buy
1,204
+1,152
+2,215% +$7.63K ﹤0.01% 6408
2020
Q3 		$0 Sell
52
-162
-76% -$802 ﹤0.01% 6589
2020
Q2 		$1K Buy
214
+26
+14% +$108 ﹤0.01% 6376
2020
Q1 		$1K Sell
188
-2,327
-93% -$15.6K ﹤0.01% 6395
2019
Q4 		$21K Buy
2,515
+2,312
+1,139% +$16.7K ﹤0.01% 5826
2019
Q3 		$1K Buy
+203
New +$1.44K ﹤0.01% 6395
2018
Q4 		– Sell
-60
Closed – – 6718
2018
Q3 		$0 Buy
+60
New +$333 ﹤0.01% 6694
2017
Q4 		– Sell
-4
Closed – – 6517
2017
Q3 		$0 Buy
+4
New +$10 ﹤0.01% 6691
2016
Q4 		– Sell
-1,000
Closed -$5K – 6616
2016
Q3 		$5K Hold
1,000
– – ﹤0.01% 5952
2016
Q2 		$2K Hold
1,000
– – ﹤0.01% 6130
2016
Q1 		$2K Hold
1,000
– – ﹤0.01% 6113
2015
Q4 		$2K Hold
1,000
– – ﹤0.01% 6346
2015
Q3 		$2K Hold
1,000
– – ﹤0.01% 6366
2015
Q2 		$3K Sell
1,000
-2,500
-71% -$6.88K ﹤0.01% 6307
2015
Q1 		$8K Buy
3,500
+2,500
+250% +$8.31K ﹤0.01% 5624
2014
Q4 		$4K Sell
1,000
-15,000
-94% -$58.3K ﹤0.01% 5840
2014
Q3 		$64K Sell
16,000
-4,000
-20% -$16.2K ﹤0.01% 4823
2014
Q2 		$73K Sell
20,000
-1,410
-7% -$5.7K ﹤0.01% 4681
2014
Q1 		$83K Sell
21,410
-8,590
-29% -$25.3K ﹤0.01% 4636
2013
Q4 		$65K Hold
30,000
– – ﹤0.01% 4783
2013
Q3 		$85K Sell
30,000
-28
-0.1% -$86 ﹤0.01% 4564
2013
Q2 		$89K Buy
+30,028
New +$101K ﹤0.01% 4369

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Royal Bank of Canada's APYX Position: Q1 2026 in Review

Royal Bank of Canada increased its Apyx Medical (APYX) stake by 21% in Q1 2026, buying an estimated $3.09K and bringing the position to 4,821 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #5933.

Royal Bank of Canada first reported a position in APYX in Q2 2013 and has held it in 38 quarters since. The position peaked at $116K in Q4 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Royal Bank of Canada held 4,821 shares of Apyx Medical worth $18K as of Q1 2026.
  • Royal Bank of Canada bought 827 Apyx Medical shares in Q1 2026, an estimated $3.09K.
  • Apyx Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5933 holding.
  • Royal Bank of Canada first reported a position in Apyx Medical in Q2 2013 and has held it in 38 quarters since.
  • Royal Bank of Canada's Apyx Medical position peaked at $116K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.